Repligen | RGEN - Spese Operative





Spese Operative Cambiamento Data
Agilent USD 1.43B 2M 2026-06
Align Technology USD 821.72M 43.15M 2026-09
Bio Techne USD 243.9M 17.7M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Bruker USD 790.5M 21.6M 2026-09
Charles River Laboratories USD 3.23B 387.38M 2026-09
Danaher USD 53.62B 1.04B 2026-09
Dentsply International USD 1.36B 4M 2026-09
General Electric Aerospace USD 17.52B 118M 2026-09
Henry Schein USD 3.27B 8M 2026-09
Illumina USD 525M 374M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Mettler Toledo International USD 77.66M 662.11M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pfizer USD 89B 3.81B 2026-09
Repligen USD 185.01M 2.01M 2026-09
Revvity USD 604.27M 719K 2026-09
Standard Biotools USD 27.93M 2.63M 2026-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Waters USD 527M 592M 2026-06
West Pharmaceutical Services USD 2.97B 22M 2026-09